Dr Charmaine GittlesonNon-Executive ChairDr Gittleson has...

Dr Charmaine GittlesonNon-Executive ChairDr Gittleson has extensive international experience as a pharmaceutical physician and enterprise leader in pharmaceutical drug development, governance and risk management gained during her 15-year tenure (2005-2020) with global specialty biotechnology company CSL Limited (ASX: CSL).During her time at CSL, Dr Gittleson had at various times accountability for clinical research, medical safety, medical and patient related ethics for development and on market programs, providing leadership in strategic product development, planning and implementation across multiple therapeutic and rare disease areas.Dr Gittleson held the key leadership roles of: Senior Director, Head Safety and Clinical Development (2006-2010) in Melbourne Australia; Vice President Clinical Strategy (2010-2013) and Senior Vice President Clinical Development (2013-2017) in Pennsylvania United States; and Chief Medical Officer in Melbourne from 2017 until her recent retirement from corporate roles in 2020.


arjay
You hold no shares
Why waste your time
You state that CG has no commercial experience
CG was involved

with taking drugs to commercialisation..

Arjay
i have posted many times
No pharma would sign up until results were a success
because
only a small Pilot trial 9 boys
Per should have done a bigger trial with at least 40 boys with placebo..

Arjay : Go visit Sam and talk rubbish